Cryptosporidium parvum/hominis

The GI Effects® Comprehensive Profile is a group of advanced stool tests that assess digestive function, intestinal inflammation, and the intestinal microbiome to assist in the management of gastrointestinal health. This is the 1-day version of the test; it is also available as a 3-day test.

The GI Effects® Comprehensive Profile is a group of advanced stool tests that assess digestive function, intestinal inflammation, and the intestinal microbiome to assist in the management of gastrointestinal health. This is the 3-day version of the test; it is also available as a 1-day test.

Measures antibodies against 32 different pathogens that may lead to autoimmune reactivities, including oral pathogens, gut pathogens, Mycoplasma, Chlamydia, Mycobacterium avium, Candida albicans, mycotoxin-producing molds (Aspergillus, Penicillium, Stachybotrys), EBV, CMV, HHV-6, and the agent and co-infections of Lyme disease. Detects possible associations between different bacteria, viruses, parasites, yeasts, and molds with more than 80 different autoimmune diseases due to cross-reactivity and molecular mimicry. It can also be used to monitor the effectiveness of various protocols in the management of autoimmune disorders triggered by pathogens. Developed and published by Aristo Vojdani, PhD, MSc, CLS, known as the father of functional immunology, in 2006, 2009, 2014, 2015, 2018, 2021, and 2024.

The GI Effects® Comprehensive Profile with Microbiomix offers metagenomic shotgun/whole genome sequencing to assess your patient's complete gut microbiome and function. Metagenomics is considered the gold-standard method to study gut microbiota.

The Parasitology Module includes microscopic fecal specimen examination for ova and parasites (O&P), as well as PCR detection of common protozoan parasites. This test can be added to the GI Effects® Fundamentals profiles.